Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : JMAR Technologies(JMAR) -- Ignore unavailable to you. Want to Upgrade?

To: brent gephart who wrote (3880)	11/7/1997 10:58:00 AM
From: Starlight	Read Replies (3) \| Respond to of 9695

Brent - You mentioned bigger competitors in the ASIC market. As I understand it, there aren't many competitors in this market, and it is a very lucrative market. I think that's why JMAR got into the ASIC market in the first place. The problems with CATS seemed to be in getting the line calibrated so that it worked properly. I'm not sure just how complicated this is or what is involved, but evidently, JMAR feels they have put enough money into CATS and would now like to get on with their other businesses that ARE working properly. Regarding the previous comment about people selling the stock because SEMATECH didn't make a decision regarding XRL -- that wouldn't be a good reason to sell, in my opinion. If SEMATECH had made a decision and it hadn't been for XRL, then I could understand some selling, but for now, XRL is going forward. Betty

To: brent gephart who wrote (3880)	11/7/1997 11:52:00 AM
From: Bilberry	Read Replies (1) \| Respond to of 9695

Brent, when I talked with the company several weeks back, it was apparent that the reason that they are not funding CATS is primarily because other product lines are taking priority, and can give a lot more bang for the buck. Why put $1 in cats if you get a return of $1.25 when you can put $1 into further development of the Mirage and get a $2.00 return. So, if JMAR did a secondary as you suggested, that money may be better put to use in some of the other emerging technologies. CATs could absolutely be profitable if they continued the development, as could have been with JMAR's former division Surgilase. Its just a matter of priorities. I think they made a great decision, and I hope that they get a partner to make it profitable. A question that came from the AOL board is whether CATS owns any real estate, and what is the total of real estate and equipment worth? --Bilberry